TAS102 in Patients With ER-positive, HER2-negative Advanced Breast Cancer

NCT04489173 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

52

Enrollment

NETWORK

Sponsor class

Conditions

Breast Neoplasm
Chemotherapy Effect

Interventions

DRUG: trifluridine/tipiracil

Sponsor

Borstkanker Onderzoek Groep

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]